Hospitals and health systems face further deterioration of operating profits as new competitors emerge like CVS Health, Amazon, and other “non-traditional entrants” into the healthcare business, Fitch Ratings says in a new report.
CVS Caremark PBM will launch a new “guaranteed net cost” drug pricing model that will return 100% of rebates to health plan clients in a move to “predictability and pricing simplicity.”
Rite Aid unveiled new governance, stripping CEO John Standley of the company’s chairmanship and adding new board members in the wake of a failed merger and mounting financial losses.
WellCare Health Plans is a potential buyer of Medicare part D drug plan assets that may have to be sold off by Aetna and CVS Health to win Justice Department approval of their merger.